Bharath Raj Palraj1, Larry M Baddour2, Erik P Hess3, James M Steckelberg1, Walter R Wilson1, Brian D Lahr4, M Rizwan Sohail2. 1. Division of Infectious Diseases. 2. Division of Infectious Diseases Division of Cardiovascular Diseases, Department of Medicine. 3. Department of Emergency Medicine and Center for Science of Healthcare Delivery. 4. Department of Biomedical Statistics and Informatics, Mayo Clinic College of Medicine, Rochester, Minnesota.
Abstract
BACKGROUND: Infective endocarditis (IE) is a serious complication of Staphylococcus aureus bacteremia (SAB). There is limited clinical evidence to guide use of echocardiography in the management of SAB cases. METHODS: Baseline and 12-week follow-up data of all adults hospitalized at our institution with SAB from 2006 to 2011 were reviewed. Clinical predictors of IE were identified using multivariable logistic regression analysis. RESULTS: Of the 757 patients screened, 678 individuals with SAB (24% community acquired, 56% healthcare associated, and 20% nosocomial) met study criteria. Eighty-five patients (13%) were diagnosed with definite IE within the 12 weeks of initial presentation based on modified Duke criteria. The proportion of patients with IE was 22% (36/166) in community-acquired SAB, 11% (40/378) in community-onset healthcare-associated SAB, and 7% (9/136) in nosocomial SAB. Community-acquired SAB, presence of cardiac device, and prolonged bacteremia (≥ 72 hours) were identified as independent predictors of IE in multivariable analysis. Two scoring systems, day 1 (SAB diagnosis day) and day 5 (when day 3 culture results are known), were derived based on the presence of these risk factors, weighted in magnitude by the corresponding regression coefficients. A score of ≥ 4 for day 1 model had a specificity of 96% and sensitivity of 21%, whereas a score of <2 for day 5 model had a sensitivity of 98.8% and negative predictive value of 98.5%. CONCLUSIONS: We propose 2 novel scoring systems to guide use of echocardiography in SAB cases. Larger prospective studies are needed to validate the classification performance of these scoring systems.
BACKGROUND: Infective endocarditis (IE) is a serious complication of Staphylococcus aureus bacteremia (SAB). There is limited clinical evidence to guide use of echocardiography in the management of SAB cases. METHODS: Baseline and 12-week follow-up data of all adults hospitalized at our institution with SAB from 2006 to 2011 were reviewed. Clinical predictors of IE were identified using multivariable logistic regression analysis. RESULTS: Of the 757 patients screened, 678 individuals with SAB (24% community acquired, 56% healthcare associated, and 20% nosocomial) met study criteria. Eighty-five patients (13%) were diagnosed with definite IE within the 12 weeks of initial presentation based on modified Duke criteria. The proportion of patients with IE was 22% (36/166) in community-acquired SAB, 11% (40/378) in community-onset healthcare-associated SAB, and 7% (9/136) in nosocomial SAB. Community-acquired SAB, presence of cardiac device, and prolonged bacteremia (≥ 72 hours) were identified as independent predictors of IE in multivariable analysis. Two scoring systems, day 1 (SAB diagnosis day) and day 5 (when day 3 culture results are known), were derived based on the presence of these risk factors, weighted in magnitude by the corresponding regression coefficients. A score of ≥ 4 for day 1 model had a specificity of 96% and sensitivity of 21%, whereas a score of <2 for day 5 model had a sensitivity of 98.8% and negative predictive value of 98.5%. CONCLUSIONS: We propose 2 novel scoring systems to guide use of echocardiography in SAB cases. Larger prospective studies are needed to validate the classification performance of these scoring systems.
Authors: J S Li; D J Sexton; N Mick; R Nettles; V G Fowler; T Ryan; T Bashore; G R Corey Journal: Clin Infect Dis Date: 2000-04-03 Impact factor: 9.079
Authors: Larry M Baddour; Walter R Wilson; Arnold S Bayer; Vance G Fowler; Ann F Bolger; Matthew E Levison; Patricia Ferrieri; Michael A Gerber; Lloyd Y Tani; Michael H Gewitz; David C Tong; James M Steckelberg; Robert S Baltimore; Stanford T Shulman; Jane C Burns; Donald A Falace; Jane W Newburger; Thomas J Pallasch; Masato Takahashi; Kathryn A Taubert Journal: Circulation Date: 2005-06-14 Impact factor: 29.690
Authors: A Incani; C Hair; P Purnell; D P O'Brien; A C Cheng; A Appelbe; E Athan Journal: Eur J Clin Microbiol Infect Dis Date: 2013-02-17 Impact factor: 3.267
Authors: Evelyn E Hill; Steven Vanderschueren; Jan Verhaegen; Paul Herijgers; Piet Claus; Marie-Christine Herregods; Willy E Peetermans Journal: Mayo Clin Proc Date: 2007-10 Impact factor: 7.616
Authors: Achim J Kaasch; Gavin Barlow; Jonathan D Edgeworth; Vance G Fowler; Martin Hellmich; Susan Hopkins; Winfried V Kern; Martin J Llewelyn; Siegbert Rieg; Jesús Rodriguez-Baño; Matthew Scarborough; Harald Seifert; Alex Soriano; Robert Tilley; M Estée Tőrők; Verena Weiß; A Peter R Wilson; Guy E Thwaites Journal: J Infect Date: 2013-11-16 Impact factor: 6.072
Authors: A D Bai; A Showler; L Burry; M Steinberg; G A Tomlinson; C M Bell; A M Morris Journal: Eur J Clin Microbiol Infect Dis Date: 2016-06-29 Impact factor: 3.267
Authors: Thomas L Holland; Larry M Baddour; Arnold S Bayer; Bruno Hoen; Jose M Miro; Vance G Fowler Journal: Nat Rev Dis Primers Date: 2016-09-01 Impact factor: 52.329
Authors: Joseph A Sivak; Amit N Vora; Ann Marie Navar; Phillip J Schulte; Anna Lisa Crowley; Joseph Kisslo; G Ralph Corey; Lawrence Liao; Andrew Wang; Eric J Velazquez; Zainab Samad Journal: J Am Soc Echocardiogr Date: 2016-02-03 Impact factor: 5.251